TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
VCEL

Vericel Corp Ord

Healthcare · Biotechnology

39.60$ -1.2% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Income Statement

Vericel Corp Ord (VCEL) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 276 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement VCEL
Line item 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
0.4 0.4 0.2 0.9 1.2 0.9 0.9 0.8 1.3 0.9 0.9 0.7 0.5 0.2 0.1 0.0 0.0 0.0 29 51 54 64 91 118 124 156 164 198 237 276
-0.5 -0.5 0.0 0.0 0.9 0.0 0.2 0.9 0.3 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 17 26 28 30 32 38 40 50 55 62 65 71
0.9 0.9 0.2 0.9 0.2 0.9 0.7 0.0 1.0 0.8 0.9 0.7 0.5 0.1 0.1 0.0 0.0 0.0 12 25 26 34 59 80 84 106 110 136 172 206
13 13 15 11 6.3 5.0 5.4 5.6 6.3 7.2 9.5 11 15 11 13 21 26 15 21 19 15 13 14 30 13 16 20 21 25 28
2.0 2.0 2.9 2.8 3.4 2.5 3.5 4.0 5.4 6.0 9.1 8.7 6.4 5.0 5.2 7.7 7.8 5.9 14 22 27 36 49 61 69 98 107 117 143 167
16 16 18 14 10.0 7.5 9.0 9.7 12 13 19 20 22 16 18 29 34 21 35 41 43 49 63 92 82 114 127 142 168 195
-15 -15 -18 -13 -9.8 -6.6 -8.3 -9.7 -11 -12 -18 -19 -21 -16 -18 -29 -34 -21 -24 -17 -19 -15 -3.9 -11 2.4 -7.9 -17 -6.5 4.5 11
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.1 1.7 0.0 0.0 0.0 0.4 0.6 0.6 1.6
-14 -17 -12 -9.4 -9.4 -7.9 -9.6 -10 -12 -12 -16 -20 -16 -18 -20 -29 -16 -20 -16 -20 -17 -8.1 -9.7 3.0 -7.6 -16 -2.4 11 17
-1.4 -0.9 -3.0 -0.4 -0.7 -0.3 -0.1 -0.2 -0.6 -1.3 -1.8 -1.1 -0.3 -0.1 -19 -4.2 -5.3 -3.6 -0.3 2.6 1.1 3.4 -1.8 0.2 -0.1 0.7 0.8 0.1 0.9
-14 -14 -17 -11 -9.4 -5.9 -7.9 -9.6 -10 -12 -16 -18 -20 -16 -18 -20 -29 -16 -20 -16 -20 -17 -8.1 -9.7 2.9 -7.5 -17 -3.2 10 17
-14 -18 -13 -9.4 -6.5 -8.2 -9.7 -10 -12 -18 -19 -20 -15 -18 -30 -19 -29 -15 -19 -15 -17 -15 -5.0 -7.9 5.4 -4.6 -12 2.9 17 30

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?